DEINOVE Logo

DEINOVE

ALDEI | PA

Overview

Corporate Details

ISIN(s):
FR0010879056 (+1 more)
LEI:
969500BEJSRFER0F2K08
Country:
France
Address:
1682 RUE DE LA VALSIERE, 34790 GRABELS
Sector:
Health Care
Industry:
Biotechnology

Description

DEINOVE is a French biotechnology company pioneering the exploration of a new domain of life, unexplored at 99.9%: the “microbial dark matter”. By revealing the metabolic potential of rare bacteria or still classified as uncultivable, it tackles a global health and economic challenge: antimicrobial resistance. The new therapies discovered and developed by DEINOVE target superbugs (microbes that have become resistant to one or more antimicrobials) that cause life-threatening infections which are now spreading at high speed.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2023-01-24 17:45
Inside Information Statement
Conversion de la procédure de redressement judiciaire en liquidation judiciaire
French 80.4 KB
2023-01-24 17:45
Inside Information Statement
Conversion of the receivership proceedings into judicial liquidation proceedings
English 67.6 KB
2023-01-16 19:09
Legal Proceedings Report
DEINOVE - Point sur la procédure de redressement judiciaire
French 79.4 KB
2023-01-16 19:09
Regulatory News Service
DEINOVE - Update on the receivership proceedings
English 66.5 KB
2022-12-16 18:10
Legal Proceedings Report
DEINOVE - Point sur la Procédure de Redressement Judiciaire
French 80.2 KB
2022-12-16 18:10
Regulatory News Service
DEINOVE - Update on the Receivership Proceedings
English 67.5 KB
2022-11-07 17:45
Inside Information Statement
Deinove annonce L’ouverture d’une procédure de redressement judiciaire
French 72.0 KB
2022-11-07 17:45
Inside Information Statement
Deinove Announces the Opening of Receivership Proceedings
English 89.5 KB
2022-10-28 17:51
Inside Information Statement
DEINOVE REQUESTS RECEIVERSHIP PROCEEDINGS
English 67.6 KB
2022-10-28 17:51
Inside Information Statement
DEINOVE SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE
French 68.6 KB
2022-10-20 17:45
Inside Information Statement
DEINOVE - Adoption of the resolutions at the Shareholders’ Extraordinary Genera…
English 69.8 KB
2022-10-20 17:45
Inside Information Statement
DEINOVE - Adoption de l'ensemble des résolutions de son Assemblée Générale Extr…
French 71.2 KB
2022-10-10 17:45
AGM Report
DEINOVE - Extraordinary General Meeting of October 17, 2022: Appointment of an …
English 86.3 KB
2022-10-10 17:45
AGM Report
DEINOVE- Assemblée générale extraordinaire du 17 octobre 2022 : Désignation d'u…
French 88.2 KB
2022-10-06 19:02
Inside Information Statement
DEINOVE présente ses résultats financiers et l’avancée de ses programmes pour l…
French 239.0 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
INTERNATIONAL BIOTECHNOLOGY TST PLC Logo INTERNATIONAL BIOTECHNOLOGY TST PLC United Kingdom IBT
Inventiva Logo Inventiva France IVA
IRLAB Therapeutics Logo IRLAB Therapeutics Sweden IRLAB
Isofol Medical Logo Isofol Medical Sweden ISOFOL
Jonix Logo Jonix Italy JNXI
Kadimastem Ltd. Logo Kadimastem Ltd. Israel KDST
Kamada Ltd. Logo Kamada Ltd. Israel KMDA
Kancera Logo Kancera Sweden KAN
Kuros Biosciences Ltd. Logo Kuros Biosciences Ltd. Switzerland KURN
Lidds AB Logo Lidds AB Sweden LIDDS